The functional NY-ESO-1 specific T cell recognition of decitabine-treated glioma cells was comparable to the recognition of a human melanoma cell line known to express high levels of NY-ESO-1 [15,30]. The gene discussed is CTAG1A; the disease is central nervous system cancer.